The consultation phase of the project to design the Certificate of suitability to the monographs of the European Pharmacopoeia (CEP) of the future has been completed.
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published the survey outcome and a roadmap for further action.
This initiative was undertaken to develop a modern CEP that will better fit the current needs of stakeholders and offer both greater transparency and enhanced user-friendliness. The first phase, starting in late 2020, involved gathering feedback from stakeholders through a wide public consultation on various aspects connected with the CEP. Responses were then compiled and reviewed in detail, making it possible to identify work areas and prepare the roadmap.
The EDQM relies on the valuable input from stakeholders to inform the development of the approach that meets their expectations.